Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fares Al-Ejeh

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 21, 2023
Cancer Incidence and Mortality Estimates in Arab Countries in 2018: A GLOBOCAN Data AnalysisMariam Al-Muftah, Fares Al-Ejeh
Experimental Cell Research|June 15, 2004
Kinetic analysis of plasminogen activator inhibitor type-2: urokinase complex formation and subsequent internalisation by carcinoma cell linesFares Al-Ejeh, David Croucher, Marie Ranson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
The La autoantigen is a malignancy-associated cell death target that is induced by DNA-damaging drugsFares Al-Ejeh, Jocelyn M Darby, Michael P Brown
Plos One|February 28, 2009
Chemotherapy synergizes with radioimmunotherapy targeting La autoantigen in tumorsFares Al-Ejeh, Jocelyn M Darby, Michael P Brown
Oncoscience|April 11, 2015
MEK5-ERK5 pathway associates with poor survival of breast cancer patients after systemic treatmentsMariska Miranda, Esdy Rozali, Kum Kum Khanna, et al.
Nuclear Medicine and Biology|May 9, 2009
A simplified suite of methods to evaluate chelator conjugation of antibodies: effects on hydrodynamic radius and biodistributionFares Al-Ejeh, Jocelyn M Darby, Benjamin Thierry, et al.
Carcinogenesis|November 19, 2011
Tocotrienol as a potential anticancer agentMing T Ling, Sze U Luk, Fares Al-Ejeh, et al.
Scientific Reports|September 9, 2017
MITF and BRN2 contribute to metastatic growth after dissemination of melanomaJacinta L Simmons, Carly J Pierce, Fares Al-Ejeh, et al.
Advanced Materials (Deerfield Beach, Fla.)|December 17, 2010
Immunotargeting of Functional Nanoparticles for MRI detection of Apoptotic Tumor CellsBenjamin Thierry, Fares Al-Ejeh, Michael P Brown, et al.
Oncotarget|August 11, 2016
RAD51 inhibition in triple negative breast cancer cells is challenged by compensatory survival signaling and requires rational combination therapyAdrian P Wiegmans, Mariska Miranda, Shu Wen Wen, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 21, 2023
Cancer Incidence and Mortality Estimates in Arab Countries in 2018: A GLOBOCAN Data AnalysisMariam Al-Muftah, Fares Al-Ejeh
Experimental Cell Research|June 15, 2004
Kinetic analysis of plasminogen activator inhibitor type-2: urokinase complex formation and subsequent internalisation by carcinoma cell linesFares Al-Ejeh, David Croucher, Marie Ranson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
The La autoantigen is a malignancy-associated cell death target that is induced by DNA-damaging drugsFares Al-Ejeh, Jocelyn M Darby, Michael P Brown
Plos One|February 28, 2009
Chemotherapy synergizes with radioimmunotherapy targeting La autoantigen in tumorsFares Al-Ejeh, Jocelyn M Darby, Michael P Brown
Oncoscience|April 11, 2015
MEK5-ERK5 pathway associates with poor survival of breast cancer patients after systemic treatmentsMariska Miranda, Esdy Rozali, Kum Kum Khanna, et al.
Nuclear Medicine and Biology|May 9, 2009
A simplified suite of methods to evaluate chelator conjugation of antibodies: effects on hydrodynamic radius and biodistributionFares Al-Ejeh, Jocelyn M Darby, Benjamin Thierry, et al.
Carcinogenesis|November 19, 2011
Tocotrienol as a potential anticancer agentMing T Ling, Sze U Luk, Fares Al-Ejeh, et al.
Scientific Reports|September 9, 2017
MITF and BRN2 contribute to metastatic growth after dissemination of melanomaJacinta L Simmons, Carly J Pierce, Fares Al-Ejeh, et al.
Advanced Materials (Deerfield Beach, Fla.)|December 17, 2010
Immunotargeting of Functional Nanoparticles for MRI detection of Apoptotic Tumor CellsBenjamin Thierry, Fares Al-Ejeh, Michael P Brown, et al.
Oncotarget|August 11, 2016
RAD51 inhibition in triple negative breast cancer cells is challenged by compensatory survival signaling and requires rational combination therapyAdrian P Wiegmans, Mariska Miranda, Shu Wen Wen, et al.
Pageof 6